Biocon Biologics Ltd., a fully integrated ‘pure play’ biosimilars company and a subsidiary of Biocon Ltd., announced that Susheel Umesh has joined Biocon Biologics as the Chief Commercial Officer – Emerging Markets (CCO-EMs) w.e.f. March 1, 2021. In this new role, Susheel will drive the company’s business in the Emerging Markets (EMs) and will also…